Product image of Minims Diagnostico Con Anestetico (Fluorescein Sodium, Lidocaine Hydrochloride) supplied by GNH India

Minims Diagnostico Con Anestetico

Active Ingredient:
Fluorescein Sodium, Lidocaine Hydrochloride
Origin:
EU

Minims Diagnostico Con Anestetico (Fluorescein Sodium, Lidocaine Hydrochloride)

Fluorescein Sodium, the active ingredient in Minims Diagnostico Con Anestetico, is a diagnostic ophthalmic dye presented as an ophthalmic solution (eye drops) for topical ocular use. It stains the corneal and conjunctival epithelium to aid visualization during eye examinations. Lidocaine Hydrochloride, also present, provides reversible local anesthesia of the ocular surface.
GNH India supplies Minims Diagnostico Con Anestetico as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Bausch + Lomb Ireland Limited

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Minims Diagnostico Con Anestetico is used in ophthalmic diagnostic and procedural settings to visualize ocular surface tissues and provide temporary anesthesia.

  • Corneal and conjunctival staining: Enables clear visualization of epithelial defects, abrasions and ulcerations during slit‑lamp examination.
  • Ocular surface anesthesia: Provides short‑acting numbing of the cornea and conjunctiva for intra‑ocular pressure measurement, fluorescein staining, and minor procedures such as foreign‑body removal.
  • Diagnostic assessment of tear film break‑up: Facilitates evaluation of tear film stability when combined with fluorescein dye.

How It Works

  • Fluorescein sodium binds to ocular surface proteins and fluoresces under cobalt‑blue illumination, highlighting epithelial defects, while lidocaine hydrochloride blocks voltage‑gated sodium channels in corneal nerve endings, producing reversible local anesthesia of the ocular surface.

Side Effects

Adverse reactions to Minims Diagnostico Con Anestetico are generally mild and related to the individual components.

Common Side Effects

  • Transient ocular stinging or burning.
  • Temporary blurred vision.
  • Mild conjunctival redness.
  • Increased tearing.

Serious or Rare Side Effects

  • Allergic contact dermatitis of the eyelid.
  • Severe corneal epithelial toxicity.
  • Anaphylactic reaction (rare).
  • Persistent corneal edema.

Precautions & Warnings

When using Minims Diagnostico Con Anestetico, consider the following precautions to ensure safety and efficacy.

  • Contraindication: Do not use in patients with known hypersensitivity to fluorescein or lidocaine.
  • Pregnancy and lactation: Use only if clearly needed; safety data are limited.
  • Contact lens wearers: Remove lenses before administration to avoid staining and irritation.
  • Repeated use: Limit frequency to avoid cumulative corneal toxicity.
  • Pediatric use: Exercise caution; dosing and frequency should be determined by an ophthalmologist.
  • Store at ambient temperature: Keep below 25 °C, protect from light and moisture in the original container.

Avoid Interactions

Minims Diagnostico Con Anestetico may interact with certain ophthalmic agents; consider the following.

Major Interactions (Avoid)

  • Concurrent use with other topical anesthetics: May increase risk of corneal toxicity.
  • Combination with ocular dyes containing similar dyes: May cause additive staining and misinterpretation.

Moderate Interactions (Monitor Closely)

  • Anticholinergic eye drops (e.g., atropine): May alter pupil response affecting fluorescein assessment.
  • Preservative‑containing solutions: Potential for increased ocular irritation.
  • Systemic lidocaine administration: May augment local anesthetic effect.

Frequently Asked Questions

Minims Diagnostico Con Anestetico is an ophthalmic solution that combines fluorescein sodium and lidocaine hydrochloride. It is used to stain the cornea and conjunctiva for diagnostic visualization and to provide short‑acting topical anesthesia during eye examinations and minor ocular procedures.

Fluorescein sodium adheres to proteins on the ocular surface and emits bright green fluorescence when illuminated with cobalt‑blue light. This contrast highlights epithelial defects, abrasions, and ulcerations, allowing clinicians to assess the health of the cornea and conjunctiva.

The prescribed amount and frequency are set by the treating ophthalmologist based on the specific diagnostic or procedural need. The product is administered as one or more drops to the ocular surface, and the prescriber decides the exact regimen.

Safety data for use in pregnancy and lactation are limited. It should be used only if clearly indicated and after a risk‑benefit assessment by the healthcare professional. Consultation with a specialist is recommended before administration to pregnant or nursing patients.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with single‑component fluorescein drops, Minims Diagnostico adds lidocaine for immediate surface anesthesia, reducing patient discomfort during staining. It offers the same diagnostic clarity as standard fluorescein solutions while eliminating the need for a separate anesthetic agent.

Store the ophthalmic solution at ambient temperature, preferably below 25 °C. Keep the bottle in its original packaging, protect it from direct light and moisture, and ensure the cap is tightly closed when not in use.

The product is applied topically to the eye as one or more drops. The patient should be instructed to tilt the head back, pull down the lower eyelid, instill the prescribed number of drops, and then close the eyes briefly to allow even distribution.

Serious but rare risks include severe allergic reactions such as contact dermatitis or anaphylaxis, and significant corneal epithelial toxicity that can lead to persistent edema or vision impairment. Any signs of severe irritation or vision loss require immediate medical attention.

Patients with a known hypersensitivity to fluorescein, lidocaine, or any excipients in the formulation should avoid this product. It is also contraindicated in individuals who have experienced severe ocular reactions to similar diagnostic dyes or local anesthetics.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Fluorescein Sodium, Lidocaine Hydrochloride

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT